Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
Aarhus Microdialysis Research Group, Aarhus University Hospital, Aarhus, Denmark.
Eur Spine J. 2022 Jun;31(6):1508-1514. doi: 10.1007/s00586-022-07208-9. Epub 2022 Apr 29.
Flucloxacillin is a frequently used antibiotic in the treatment of spondylodiscitis. We assessed steady-state concentrations and time above minimal inhibitory concentration (fT > MIC) of flucloxacillin in the intervertebral disc, vertebral cancellous bone, subcutaneous tissue and plasma, after intravenous and oral administration.
Sixteen pigs were randomized into two groups; Group Peroral (Group PO) and Group Intravenous (Group IV) received 1 g flucloxacillin every 6 h for 24 h orally or intravenously. Microdialysis was used for sampling in the compartments of interest. A flucloxacillin target of 50% fT > MIC was applied for three MIC targets: 0.125, 0.5 and 2.0 μg/mL.
Intravenous administration resulted in significantly longer fT > MIC for all targets. Target attainment was only reached for the low target of 0.125 μg/mL in Group IV in vertebral cancellous bone, subcutaneous tissue, and plasma (intervertebral disc 47%). In Group IV, mean fT > MIC values in the investigated compartments were in the range of 47-67% of the dosing interval for 0.125 μg/mL, 20-35% for 0.5 μg/mL, and 0-15% for 2.0 μg/mL. In Group PO, mean fT > MIC values for 0.125 μg/mL were in the range of 1-33%. No pigs reached a concentration of 0.5 μg/mL in any of the investigated compartments in Group PO.
Administration of 1 g flucloxacillin every 6 h resulted in surprisingly low steady-state fT > MIC after intravenous and oral administration. However, intravenous administration resulted in significantly higher concentrations across compartments compared to oral administration. Sufficient target tissue concentrations for treatment of spondylodiscitis may require a dose increase or alternative dosing regimens.
氟氯西林是治疗椎间盘炎的常用抗生素。我们评估了静脉和口服给药后氟氯西林在椎间盘、椎体松质骨、皮下组织和血浆中的稳态浓度和高于最小抑菌浓度的时间(fT> MIC)。
将 16 头猪随机分为两组;口服组(Group PO)和静脉组(Group IV)分别给予 1g 氟氯西林,每 6 小时静脉或口服 1 次,共 24 小时。采用微透析法对感兴趣的部位进行采样。应用 50% fT> MIC 的氟氯西林目标浓度,针对三个 MIC 目标:0.125、0.5 和 2.0μg/mL。
静脉给药使所有目标的 fT> MIC 时间明显延长。仅在静脉组的低目标(0.125μg/mL)下,达到了 0.125μg/mL 的低目标,在椎体松质骨、皮下组织和血浆中(椎间盘 47%)达到了目标。在静脉组中,在研究的各个部位,0.125μg/mL 时的平均 fT> MIC 值为给药间隔的 47-67%,0.5μg/mL 时为 20-35%,2.0μg/mL 时为 0-15%。在口服组中,0.125μg/mL 时的平均 fT> MIC 值为 1-33%。在口服组的任何研究部位,均未达到 0.5μg/mL 的浓度。
每 6 小时给予 1g 氟氯西林,静脉和口服给药后,稳态 fT> MIC 均出乎意料地低。然而,与口服给药相比,静脉给药使各部位的浓度显著升高。为治疗椎间盘炎,可能需要增加剂量或采用替代给药方案,以达到足够的靶组织浓度。